Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Revision History For: PWRM - Power3 Medical Products, Inc.

No earlier versions found for this Subject.

Return to PWRM - Power3 Medical Products, Inc.

Power3 Medical Products, Inc. (Pink PWRM): is a breakthrough proteomics company specializing in the identification of disease footprints in the areas of chemotherapeutic drug resistance and the early detection of breast cancer and neurological diseases. The research platform is centered on the study of proteomics, the science of protein interactions within living cells. With a combined 50+ years of proteomic experience, the Company has identified 334 protein biomarkers with the following potential medical applications: Breast Cancer Chemotherapeutic Drug Resistance Alzheimer's disease Leukemia ALS (Lou Gehrig's Disease) Gastrointestinal Disease Parkinson's Disease Metabolic Syndrome
Website: power3medical.com